SAN DIEGO, Oct. 9, 2012 — Genalyte Inc.’s custom spotting service provides scientists with flexibility in designing multiplex assay panels for research. The service loads proteins such as antibodies, peptides, biomarkers, cytokines and antigens supplied by customers onto Genalyte chips. The chips are then returned to the customer in the same ready-to-use chip array format used in the company’s off-the shelf multiplex assay kits, ready to be run on the Maverick multiplex detection system, which delivers results from small samples of many types, including serum, plasma, culture media and whole blood.
Maverick and its ENA 4 and ENA 6 assay kits simultaneously screen for several of the most common autoantibodies found in autoimmune connective tissue disorders, such as systemic lupus erythematosus (SLE). Assay kits for advanced SLE testing, rheumatoid arthritis and Type 1 diabetes are available under the Genalyte Technology Access program. The simplified one-step work flow of the Maverick assays delivers accurate results in 15 min, and the assays can be run using very small volume samples from a variety of matrices, including serum and plasma. Semiquantitative results are reported for each analyte, eliminating the need for reflex testing. The Maverick platform has a high dynamic range and good sensitivity and reproducibility.
For more information, visit www.genalyte.com
To contact the manufacturer of this product, click here